MENUMENU

About
Initiatives
Events
Membership
- Become a Member
- Practice in Focus
Community
News
OPTA
Oncolytics Today
COVID-19 Resources
Login
Register
Contact

Home Team Becki Tinder

27

Becki Tinder

May 27, 2020 Victoria

Victoria

Victoria has blogged 320 posts

Barry D. Brooks
Taryn Newsome

Support NCODA’s Patient-Centered Initiatives

NCODA News

Pralsetinib Management for Metastatic RET Fusion-positive Non-Small Cell Lung Cancer
ANY WILLING PROVIDER (AWP) – STILL A MAJOR ISSUE IN ONCOLOGY
FDA approves Libtayo® (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50%

2021 Spring Forum

ONCOLYTICS TODAY FALL 2020 ISSUE AVAILABLE NOW!

February 2021
M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28

« Jan

Contact

P.O. Box 468
Cazenovia, NY 13035

contact@ncoda.org

315-655-4640
a 501(c)(3) Organization

Passion for Patients

315-655-4640
contact@ncoda.org